“…GVHD can rarely affect both the central and peripheral nervous systems in the form of cerebrovascular disease, demyelinating disease, immune-mediated encephalitis, PTLDs, myositis, neuropathies, and myasthenia gravis. 2 There are specific concerns regarding different chemotherapeutic agents, which are extensively discussed elsewhere. 3 The anesthetic implications of the different immunomodulatory agents and radiotherapy are described in ►Table 1.…”